SB

Siddharth Bhavsar

Active Director Director DIN 06994681
DIN 06994681 First appointment Oct 2014 Primary industry Research & Development
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Oct 2014
Shareholding value •••• Premium profile

About Siddharth Bhavsar

Data last updated:

Siddharth Bhavsar is a Director at Giostar Healthcare Private Limited (since 2020), Director at Giostar Research Private Limited (since 2015) and Director at Blue Ocean Labs Private Limited (since 2022). The companies operate in Research & Development, Life Sciences and Recycling & Waste Management. The 2 current companies with reported revenue have a combined latest revenue of ₹4.13 Cr; the largest is Giostar Healthcare Private Limited at ₹2.23 Cr (FY 2025). Earlier, Siddharth Bhavsar was a Director at Graphene Research Labs Private Limited (2021–2024) and Additional Director at Heamgen Research Private Limited (from 2014).

DIN 06994681
Primary Designation Director
Industry Research & Development
First Appointment 18 Oct 2014
Oldest Company Age 30 yrs
Largest company Giostar Healthcare Private Limited · ₹2.23 Cr (FY 2025)
Combined revenue ₹4.13 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Giostar Healthcare Private Limited U73100GJ2020PTC112346
Director28 Jan 20202020₹2.23 Cr (FY 2025)Active
Giostar Research Private Limited U73100GJ2009PTC058156
Director15 Mar 20152009₹1.90 Cr (FY 2023)Active
Blue Ocean Labs Private Limited U90000DL2022PTC403430
Director22 Aug 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jan 20212020Active
Heamgen Research Private Limited U73100DL1996PTC081155
Additional Director18 Oct 20141996₹13.2 Lakh (FY 2017)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Heamgen Research Private Limited
Giostar Research Private Limited
Giostar Healthcare Private Limited
Blue Ocean Labs Private Limited
Premium access

Shareholding and investment profile for Siddharth Bhavsar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siddharth Bhavsar

Siddharth Bhavsar currently holds 3 directorships: Giostar Healthcare Private Limited (Director, since 28 Jan 2020, revenue ₹2.23 Cr (FY 2025)); Giostar Research Private Limited (Director, since 15 Mar 2015, revenue ₹1.90 Cr (FY 2023)); Blue Ocean Labs Private Limited (Director, since 22 Aug 2022).

Siddharth Bhavsar was first appointed on 18 Oct 2014 as Additional Director at Heamgen Research Private Limited. The most recent appointment on record is 22 Aug 2022 at Blue Ocean Labs Private Limited.

The 2 current companies of Siddharth Bhavsar that report revenue have a combined latest revenue of ₹4.13 Cr: Giostar Healthcare Private Limited ₹2.23 Cr (FY 2025); Giostar Research Private Limited ₹1.90 Cr (FY 2023).

Siddharth Bhavsar held 2 earlier board appointments: Graphene Research Labs Private Limited (Director, 18 Jan 2021 to 20 Jan 2024); Heamgen Research Private Limited (Additional Director, from 18 Oct 2014).

The current boards of Siddharth Bhavsar's companies include Anand Srivastava Shanker (Giostar Healthcare Private Limited), Deven Jitendra Patel (Giostar Healthcare Private Limited), Rekha Rajnish (Giostar Healthcare Private Limited), Renu Gandotra (Giostar Healthcare Private Limited), Reva Gandhi (Giostar Healthcare Private Limited), Rita Gupta (Giostar Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available